ArticleRSC advances2022

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens.

Tarfah Al-Warhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.